Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
David MG Halpin. (2023) Clinical Management of COPD in the Real World: Can Studies Reveal Errors in Management and Pathways to Improve Patient Care?. Pragmatic and Observational Research 14, pages 51-61.
Read now
Read now
David Mannino, James Siddall, Mark Small, Adam Haq, Marjorie Stiegler & Michael Bogart. (2022) Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 749-761.
Read now
Read now
Kjell Larsson, Ann Ekberg-Jansson, Caroline Stridsman, Malin Hanno & Lowie E G W Vanfleteren. (2021) Adherence to Treatment Recommendations for Chronic Obstructive Pulmonary Disease - Results from the Swedish National Airway Register. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 909-918.
Read now
Read now
Articles from other publishers (11)
John R. Hurst, MeiLan K. Han, Barinder Singh, Sakshi Sharma, Gagandeep Kaur, Enrico de Nigris, Ulf Holmgren & Mohd Kashif Siddiqui. (2022) Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respiratory Research 23:1.
Crossref
Crossref
Nikolaos Tzanakis, Nikolaos Koulouris, Katerina Dimakou, Konstantinos Gourgoulianis, Epameinondas Kosmas, Georgia Chasapidou, Athanasios Konstantinidis, Christos Kyriakopoulos, Theodoros Kontakiotis, Aggeliki Rapti, Mina Gaga, Konstantinos Kalafatakis & Konstantinos Kostikas. (2021) Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Hye Seon Kang, Sung Kyoung Kim, Yong Hyun Kim, Jin Woo Kim, Sang Haak Lee, Hyung Kyu Yoon & Chin Kook Rhee. (2021) The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Meng-Ting Wang, Jyun-Heng Lai, Ya-Ling Huang, Jun-Ting Liou, Shih-Hsuan Cheng, Chen Wei Lin, Hsueh-Yi Pan, Yu-Juei Hsu & Chen-Liang Tsai. (2021) Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study. Chest 160:4, pages 1255-1270.
Crossref
Crossref
Lai-Jian Cen, Xiao-xian Zhang & Wei-Jie Guan. (2021) Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?. ERJ Open Research 7:3, pages 00362-2021.
Crossref
Crossref
T. Greulich, V. Töpfer, M. Hennig, C. C. Orehounig, K. Ams, C. D. Mohrlang, P. H. Killian & P. Kardos. (2020) COPD in Germany: Use of Diagnostic Measures Including Blood Eosinophil Counts in Daily Practice. Pneumologie 75:05, pages 344-352.
Crossref
Crossref
Mario Cazzola, Maria Gabriella Matera & Paola Rogliani. (2021) Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?. US Respiratory & Pulmonary Diseases 6:1, pages 31.
Crossref
Crossref
Dave Singh, Jadwiga A. Wedzicha, Salman Siddiqui, Alberto de la Hoz, Wenqiong Xue, Helgo Magnussen, Marc Miravitlles, James D. Chalmers & Peter M. A. Calverley. (2020) Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials. Respiratory Research 21:1.
Crossref
Crossref
Julianna Photopoulos. (2020) Should physicians still be prescribing steroid inhalers as a first-line treatment for COPD?. Nature 581:7807, pages S12-S13.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal & Bernardino Alcázar Navarrete. (2020) Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente. Archivos de Bronconeumología 56:4, pages 242-248.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal & Bernardino Alcázar Navarrete. (2020) The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient. Archivos de Bronconeumología (English Edition) 56:4, pages 242-248.
Crossref
Crossref